Does CABERGOLINE Cause Product use in unapproved indication? 61 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Product use in unapproved indication have been filed in association with CABERGOLINE (Cabergoline). This represents 2.9% of all adverse event reports for CABERGOLINE.
61
Reports of Product use in unapproved indication with CABERGOLINE
2.9%
of all CABERGOLINE reports
0
Deaths
21
Hospitalizations
How Dangerous Is Product use in unapproved indication From CABERGOLINE?
Of the 61 reports, 21 (34.4%) required hospitalization, and 2 (3.3%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABERGOLINE. However, 61 reports have been filed with the FAERS database.
What Other Side Effects Does CABERGOLINE Cause?
Drug ineffective (249)
Headache (142)
Off label use (129)
Nausea (103)
Maternal exposure during pregnancy (100)
Dizziness (94)
Cerebrospinal fluid leakage (78)
Fatigue (71)
Malaise (64)
Condition aggravated (61)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which CABERGOLINE Alternatives Have Lower Product use in unapproved indication Risk?
CABERGOLINE vs CABOTEGRAVIR
CABERGOLINE vs CABOTEGRAVIR\RILPIVIRINE
CABERGOLINE vs CABOZANTINIB
CABERGOLINE vs CABOZANTINIB S-MALATE
CABERGOLINE vs CAFFEINE